Nilutamide
| Nilutamide | |
|---|---|
| Term | Nilutamide |
| Short definition | NILM - A Pap test finding that means no cancer cells or other abnormal cells were found on the surface or in the tissues lining the cervix. Cellular changes that indicate inflammation or infection may be included in this finding. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Nilutamide - (pronounced) (ny-LOO-tuh-mide) drug used to treat prostate cancer that has spread to other parts of the body. It is used in patients who have had an operation (orchiectomy) on their testicles. Nilutamide attaches to proteins called androgen receptors, which are found in some prostate cancer cells. These proteins bind to androgens (male hormones) and can cause cancer cells to grow. Nilutamide blocks these proteins and can prevent cancer cells from growing. It's a type of antiandrogen. Also called Nilandron
External links
- Medical encyclopedia article on Nilutamide
- Wikipedia's article - Nilutamide
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski